PHARMACEUTICAL PRODUCT DEVELOPMENT INC 4
4 · PHARMACEUTICAL PRODUCT DEVELOPMENT INC · Filed Feb 15, 2006
Insider Transaction Report
Form 4
DAVENPORT FRED B JR
President
Transactions
- Sale
Common Stock
2006-02-15$66.20/sh−2,500$165,500→ 66,366 total - Sale
Common Stock
2006-02-15$66.12/sh−1,500$99,180→ 61,366 total - Exercise/Conversion
Common Stock
2006-02-15$30.10/sh+25,000$752,500→ 68,866 total - Sale
Common Stock
2006-02-15$66.15/sh−2,000$132,300→ 55,866 total - Exercise/Conversion
Common Stock
2006-02-15$26.22/sh+5,000$131,100→ 43,866 total - Sale
Common Stock
2006-02-15$66.10/sh−7,500$495,750→ 38,866 total - Sale
Common Stock
2006-02-15$66.03/sh−1,000$66,030→ 65,366 total - Exercise/Conversion
Stock Options (to buy)
2006-02-15−25,000→ 165,000 totalExercise: $30.10From: 2005-01-15Exp: 2012-01-14→ Common Stock (25,000 underlying) - Exercise/Conversion
Stock Options (to buy)
2006-02-15−5,000→ 190,000 totalExercise: $26.22From: 2004-12-03Exp: 2011-12-02→ Common Stock (5,000 underlying) - Sale
Common Stock
2006-02-15$66.05/sh−5,000$330,250→ 48,866 total
Footnotes (1)
- [F1]8,333 shares were vested and exercisable on 1/15/03; 8,333 shares were vested and exercisable on 1/15/04 and 8,334 shares were vested and exercisable on 1/15/05.